Currie BJ, Ward L, Cheng AC. The epidemiology and clinical spectrum of melioidosis: 540 cases from the 20 year Darwin prospective study. PLoS Negl Trop Dis. 2010;4(11):e900.
Wuthiekanun V, Peacock SJ. Management of melioidosis. Expert Rev Anti Infect Ther. 2006;4(3):445-455.
[6]
Inglis TJJ, Aravena-Roman M, Ching S, et al. Rapid identification of Burkholderia pseudomallei with a monoclonal antibody. J Clin Microbiol. 2003;41(2):844-845.
[7]
Supputtamongkol Y, Chaowagul W, Chetchotisakd P, et al. Risk factors, clinical presentations and outcomes of melioidosis. Trans R Soc Trop Med Hyg. 1999;93(5):515-518.
[8]
Keto R, Currie B, Mayo M, et al. The Darwin Prospective Melioidosis Study: a 30-year study of melioidosis in the Top End of the Northern Territory, Australia. Med J Aust. 2023;218(5):214-219.